Cancer Heterogeneity and Plasticity

Editorial Board

  • Dean Tang
    Dean Tang   MD, PhD

    Professor and Chair, Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center (RPCCC), USA

    Research Interests: Cancer cell heterogeneity and plasticity; cancer stem cells; prostate cancer; non-coding RNAs and epigenetic regulation of cell state

    E-Mail | Website
Associate Editor
  • Jinsong Liu
    Jinsong Liu   MD, PhD

    Professor, Department of Pathology and Laboratory Medicine; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, USA

    Research Interests: Ovarian cancer; cancer stem cells; tumor phenotypes; inflammation and genomic reorganization in cancer progression; cancer models; markers for diagnosis, prognosis, and therapeutic response; gynecologic pathology

    E-Mail | Website
  • Amina  Zoubeidi
    Amina Zoubeidi   PhD

    Canada Research Chair (Tier 1) in Cancer Therapy Resistance
    Professor of Department of Urologic Sciences, University of British Columbia, Canada

    Research Interests: Prostate cancer; treatment resistance; phenotypic plasticity

    E-Mail | Website
Advisory Board Member
  • David W. Goodrich
    David W. Goodrich   PhD

    Distinguished Professor of Oncology, Department of Pharmacology & Therapeutics;
    Director of Genitourinary Oncology Research, Department of Urology;
    Associate Dean for Postdoctoral Education, Roswell Park Comprehensive Cancer Center (RPCCC), USA

    Research Interests: Tumor suppressor gene function and regulation; cancer lineage plasticity; retroviral recombination; cancer initiation, progression and therapeutic resistance

    E-Mail | Website
Editorial Board Member
  • Yu-Chih Chen
    Yu-Chih Chen   PhD

    Assistant Professor, UPMC Hillman Cancer Center, Department of Computational and Systems Biology, University of Pittsburgh School of Medicine; Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, USA

    Research Interests: Single-cell analysis; cellular heterogeneity; cell migration; cancer-stromal engulfment; deep learning; cancer precision medicine

    E-Mail | Website
  • Anna  Dubrovska
    Anna Dubrovska   PhD

    Professor and Head of Group "Biomarkers for Individualized Radiotherapy", OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf; German Cancer Research Center (DKFZ); German Cancer Consortium (DKTK), Germany

    Research Interests: Cancer stem cells; biomarkers; individualized radiotherapy

    E-Mail | Website
  • Amir Goldkorn
    Amir Goldkorn   MD

    Professor of Medicine and Biochemistry & Molecular Medicine, Keck School of Medicine, the University of Southern California, USA

    Research Interests: developing the therapeutic and biomarker potential of liquid biopsies, cancer plasticity, and telomerase

    E-Mail | Website
  • Housheng Hansen He
    Housheng Hansen He   PhD

    Canada Research Chair (Tier 1) in RNA Medicine
    Senior Scientist, Princess Margaret Cancer Centre, University Health Network
    Professor, Department of Medical Biophysics, University of Toronto, Canada

    Research Interests: Cancer genomics; epigenomics; noncoding RNA; RNA therapy

    E-Mail | Website
  • James Jackson
    James Jackson   PhD

    Associate Professor, Department of Biochemistry and Molecular Biology, Tulane School of Medicine, USA

    Research Interests: Breast cancer tumorigenesis and drug response; cellular senescence; mouse models; mouse genetics; tumor suppressor mechanism of action; p53 cellular senescence; including mechanisms of induction, chromatin changes and consequences to organisms

    E-Mail | Website
  • Toru Kondo
    Toru Kondo   PhD

    Distinguished Professor, Division of Stem Cell Biology, Institute for Genetic Medicine, Hokkaido University, Japan

    Research Interests: Characterizing the glioma-initiating cells (GIC) induced from neural stem cells (NSC) and oligodendrocyte precursor cells (OPC), find GIC-specific factors and develop new therapeutic strategies; characterizing factors involved in NSC/OPC senescence and investigate the relationship between candidate factors and age-related disorders

    E-Mail | Website
  • Justin D.  Lathia
    Justin D. Lathia   PhD

    Vice Chair and Associate Professor, Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, USA
    Professor, Department of Molecular Medicine, School of Medicine, Case Comprehensive Cancer Center, Case Western Reserve University, USA

    Research Interests: Malignant brain tumors; glioblastoma; cancer stem cells; cell-cell communication; cell adhesion; sex differences

    E-Mail | Website
  • Suling Liu
    Suling Liu   PhD

    Professor, Cancer Institute & Institutes of Biomedical Sciences, Shanghai Cancer Center, Key Laboratory of Breast Cancer in Shanghai, Fudan University, China

    Research Interests: The origin and regulation of breast cancer stem cell heterogeneity; The role and regulation of heterogeneous breast cancer stem cells on breast cancer drug resistance and metastasis; The interaction of breast cancer stem cells and tumor microenvironment; The immuno-regulation of breast cancer stem cells; The development of potential therapeutic approaches and drugs to target breast cancer stem cells

    E-Mail | Website
  • Xiaoqi Liu
    Xiaoqi Liu   PhD

    Chair and Professor, Department of Toxicology and Cancer Biology, Lucille P. Markey Endowed Chair in Oncology Research, University of Kentucky College of Medicine, USA

    Research Interests: Cancer biology; signaling transduction; cell cycle regulation; DNA damage repair; therapy resistance; anti-cancer drugs; prostate cancer; pancreatic cancer; melanoma; lung cancer

    E-Mail | Website
  • Irene Oi Lin  Ng
    Irene Oi Lin Ng   MD, PhD

    Professor and Chair of Pathology, Department of Pathology; Director of State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong

    Research Interests: Liver cancer; molecular pathology and oncology; genomics and genetics; precision oncology

    E-Mail | Website
  • Bruno  Sainz, Jr.
    Bruno Sainz, Jr.   PhD

    Senior Researcher, Head of Cancer Stem Cells and Fibroinflamatory Microenvironment Group, Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM) - CSIC-UAM;
    Head of Biomarkers and Personalized Approach to Cancer (BIOPAC) Group;
    Co-director of Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Universidad Autónoma de Madrid, Spain

    Research Interests: Cancer; cancer stem cells (CSC); CSC-mediated tumorigenesis and metastasis; pancreatic cancer; colon cancer; fibroinflammatory tumor microenvironment; tumor-associated macrophages; pre-metastatic tumor niche; immune-based anti-cancer therapies; anti-CSC drug screening; small animal models of cancer and infectious disease (chimeric mice and transgenic mice); nanotechnology; viral-mediated cancer

    E-Mail | Website
  • Xiling Shen
    Xiling Shen   PhD

    Professor, GI Medical Oncology, MD Anderson Cancer Center; Chief Scientific Officer and Professor, Terasaki Institute for Biomedical Innovation, USA

    Research Interests: Cancer metastasis; precision medicine; Gut-brain axis and neuromodulation; intravital imaging

    E-Mail | Website
  • Jindan Yu
    Jindan Yu   MD, PhD

    Professor of Urology, Vice Chair for Research, Department of Urology; Professor of Human Genetics, Faculty Lead for Cancer Genomics, Department of Human Genetics; Scientific Director for Prostate and GU Cancers Research, Winship Cancer Institute, Emory University, USA

    Research Interests: Prostate cancer; cancer genetics and epigenetic; genomics and bioinformatics methodologies; prognostic and therapeutic biomarkers

    E-Mail | Website
  • Dingxiao Zhang
    Dingxiao Zhang   PhD

    Professor, School of Biomedical Sciences, Hunan University, China

    Research Interests: Cancer stem cells; prostate cancer; gene expression regulation; epigenetics; therapeutic targeting

    E-Mail | Website
  • Helen He  Zhu
    Helen He Zhu   PhD

    Professor, State Key Laboratory of Systems Medicine for Cancer; Med-X Clinical Stem Cell Research Center; Shanghai Cancer Institute and Department of Urology; Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, China

    Research Interests: Adult tissue stem cells from hematopoietic system and prostate in tissue development and tumorigenesis; tumor microenvironment with a focus on cancer-associated fibroblasts and nerves; development of novel targeted therapy for castration-resistant and metastatic prostate cancer

    E-Mail | Website

About Us Journals Join Us Submit Fees Contact